Get started
Author

Masahiro Hiratochi

Observed name: Hiratochi, Masahiro
OpenAlex ID: A5007510332
Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level
2006 · Kenji Katsuno, Yoshikazu Fujimori, et al. · Journal of Pharmacology and Experimental Therapeutics · 268
SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose
2004 · Shigeki Tazawa, Tokuhisa Yamato, et al. · Life Sciences · 204
The Delta intracellular domain mediates TGF-β/Activin signaling through binding to Smads and has an important bi-directional function in the Notch–Delta signaling pathway
2007 · Masahiro Hiratochi, Hisashi Nagase, et al. · Nucleic Acids Research · 78
PDF
The intracellular domain of amyloid precursor protein induces neuron-specific apoptosis
2008 · Kohzo Nakayama, Takeshi Ohkawara, et al. · Neuroscience Letters · 51
Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout
2016 · Kazuya Tatani, Masahiro Hiratochi, et al. · Journal of Medicinal Chemistry · 26
Participation of thromboxane A2 in the cough response in guinea‐pigs: antitussive effect of ozagrel
2000 · Kazuhiko Shinagawa, Masami Kojima, et al. · British Journal of Pharmacology · 25
PDF
Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides
2012 · Masahiro Hiratochi, Kazuya Tatani, et al. · European Journal of Pharmacology · 22
Identification of 8-Aminoadenosine Derivatives as a New Class of Human Concentrative Nucleoside Transporter 2 Inhibitors
2015 · Kazuya Tatani, Masahiro Hiratochi, et al. · ACS Medicinal Chemistry Letters · 20
Similar Mechanisms Regulated by γ-Secretase are Involved in Both Directions of the Bi-Directional Notch-Delta Signaling Pathway as well as Play a Potential Role in Signaling Events Involving Type 1 Transmembrane Proteins
2008 · Kohzo Nakayama, Hisashi Nagase, et al. · Current Stem Cell Research & Therapy · 16
Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor
2021 · Kazuo Shimizu, Hideki Fujikura, et al. · Bioorganic & Medicinal Chemistry · 13
Inhibition of interleukin 5 production with no influence on interleukin 4 production by an anti-allergic drug, tranilast, in Toxocara canis-infected mice
2000 · Masahiro Hiratochi, Masaya Takamoto, et al. · International Journal of Immunopharmacology · 12
Multiple POU-binding motifs, recognized by tissue-specific nuclear factors, are important for Dll1 gene expression in neural stem cells
2004 · Kohzo Nakayama, Kazuko Nagase, et al. · Biochemical and Biophysical Research Communications · 6
Function and expression differences between ergot and non-ergot dopamine D2 agonists on heart valve interstitial cells.
2014 · Fumiki Oana, Hiroshi Onozuka, et al. · PubMed · 5
Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions
2015 · Akihiro Tsuchioka, Fumiki Oana, et al. · Neuroreport · 3
Morphogenic activity of fibroblast growth factor‐2 on primary neural precursor cells in three‐dimensional culture
1998 · Masahiro Hiratochi, Akiyori Fujiwara, et al. · Development Growth & Differentiation · 3
Corrigendum to “SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-d-glucitol, and fructose” [Life Sciences 76 (2005) 1039–1050]
2010 · Shigeki Tazawa, Tokuhisa Yamato, et al. · Life Sciences · 2
CCDC 2034277: Experimental Crystal Structure Determination
2021 · Shimizu, Kazuo, Fujikura, Hideki, et al. · The Cambridge Structural Database
Works count: 24
Citation count: 754
H-index: 11
I10-index: 11
Year
Topic
Type